Mallinckrodt PLC
MNK
Delayed Nyse - 01/17 10:02:01 pm
22.28USD
-3.67%
Prev.23.1300
Open22.7900
High23.0900
Low22.2300
Volume2 431 732
Last news
Financials
Sales 2017 3 200 M
EBIT 2017 1 193 M
R. net 2017 437 M
Debt 2017 5 242 M
Rend. 2017 -
P/E ratio 2017 6,51
P/E ratio 2018 11,87
EV / Sales 2017 2,30x
EV / Sales 2018 2,18x
Capitalization 2 117 M
Company
Mallinckrodt Plc operates as a global specialty pharmaceuticals company.It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents.It operates through the following segments: Specialty Brands, Specialty Generics, and...
Sector :
Specialty & Advanced Pharmaceuticals
Calendar :
2018-02-27 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance24,132,134,3
Spread/Res.-7,4%-31%-35%
Spread/Supp.4,8%12%5,0%
Support21,320,021,2